From: Improving production of Streptomyces griseus trypsin for enzymatic processing of insulin precursor
Strains | Production | Strategies | References |
---|---|---|---|
S. lividans 1326 | 6.6 U mL−1 | pWHM3- sprT, recombinant expression | [55] |
S. lividans TK24 | 7.4 U mL−1 | Recombinant expression | [56] |
S. griseus IFO13350 (pWHM3-TR1R2) | 12.84 U mL−1 | Co-expressing positive regulatory genes sgtR1, sgtR2; medium optimization (5.5-fold increased) | [19] |
S. griseus IFO13350 (pWHM3-TR1R2) | 15.18 U mL−1 | Expression vectors containing sprT, sgtR1, and sgtR2 | [18] |
E. coli | – | – | [16] |
Bacillus subtilis SCK6 | 33.8 U mL−1 | Streptomyces trypsin GM2938 | [30] |
Pichia pastoris | 14.4 U mL−1 | Mature SGT sequence; propeptide swap; fed-batch fermentation | [20] |
P. pastoris | 1.45 U mL−1 | Propeptide engineering; 6.71-fold increased (flask culture) | [21] |
P. pastoris | 47.4 U mL−1 | Auto-catalyzed N-terminal peptide; fed-batch fermentation | [22] |
P. pastoris GS115-tbcf (101A)* | 40.5 U mL−1 | Pro-peptide mutation; artificial pro-peptide; single mutation of autolysis residues (flask culture) | [13] |
P. pastoris GS115-tbcf (101A) | 227.65 U mL−1 | Fed-batch fermentation | [13] |
GS115-tbcf (K101A, R201V) | 60.85 U mL−1 | tbcf (K101A, R201V) mutant, 1.5-fold increased (flask culture) | In study |
GS115-tbcf (K101A, R201V)-UBC1 | 80.1 U mL−1 | Overexpression UBC1, 1.98-fold increased (flask culture) | In study |
GS115-tbcf (K101A, R201V)-SSO2 | 86.12 U mL−1 | Overexpression SSO2, 2.13-fold increased (flask culture) | In study |
GS115-tbcf (K101A, R201V)-SU | 109.25 U mL−1 | Overexpression SSO2 and UBC1, 2.7-fold increased (flask culture) | In study |
GS115-tbcf (K101A, R201V)-SU | 689.47 U mL−1 | Fed-batch fermentation, threefold increased from GS115-tbcf (101A) | In study |